As an industrial French family group, DOLIAM invests in, supports and accompanies innovative start-ups and companies in MedTech, DeepTech and healthcare, developing today the solutions of tomorrow with breakthrough technologies.

Anchored at the heart of the high-tech industry, the DOLIAM Group is recognized as a benchmark player in the market, especially through its subsidiaries such as VERMON and CAIRDAC for their innovative medical technologies, MODULEUS and OLYTHE for their asset and personal protection technologies, VITRUVENS for its energy optimization devices or IC'ALPS for its integrated circuit technologies dedicated, among others, to the healthcare markets, PCB-CONCEPT for printed circuit design and ID4US which is reinventing biometrics.

The DOLIAM Group also invests in start-ups developing revolutionary medical devices and technologies, such as FINEHEART and its unique device for the treatment of severe heart failure, ICONEUS and its first neurofunctional ultrasound imaging system, and INJECTPOWER, which is developing an energy storage and microbattery technology for implantable medical devices.